miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Animals
Cadherins
/ metabolism
Cell Line
Diabetic Nephropathies
/ genetics
Epithelial-Mesenchymal Transition
/ drug effects
Fibrosis
/ genetics
Glucose
/ pharmacology
Humans
Hyperglycemia
/ genetics
Kidney
/ metabolism
Kidney Diseases
/ genetics
Male
Mice
MicroRNAs
/ genetics
Snail Family Transcription Factors
/ genetics
Vimentin
/ metabolism
Diabetic kidney disease (DN)
Epithelial-to-mesenchymal transition (EMT)
SNAI1
miR-30b-5p
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
08 01 2021
08 01 2021
Historique:
received:
07
10
2020
accepted:
29
10
2020
pubmed:
1
1
2021
medline:
10
4
2021
entrez:
31
12
2020
Statut:
ppublish
Résumé
Renal tubulointerstitial fibrosis plays a significant role in the development of diabetic nephropathy (DN). SNAI1 is a main activator of epithelial-to-mesenchymal transition (EMT) in the process of fibrosis. This study aimed to investigate the effect of miR-30b-5p targeting SNAI1 on the EMT in DN. Bioinformatics and miRNAs microarray analyses were used to predict the candidate miRNA targeting SNAI1, that is miR-30b-5p. The db/db mice was as DN animal model and renal tissues of mice were stained with PAS. The miR-30b-5p expression in mouse and human renal tissue were examined by quantitative RT-PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), while SNAI1 expression was determined by qRT-PCR and immunohistochemistry. Luciferase reporter gene assay was used to confirm miR-30b-5p directly target 3'-UTR of the SNAI1 mRNA. In vitro, HK-2 cells were treated with high glucose to establish hyperglycemia cell model and transfected with miR-30b-5p mimics to overexpress miR-30b-5p. Expression of miR-30b-5p, SNAI1 and EMT related indicators (E-cadherin, a-SMA and Vimentin) in HK-2 cells under different treatments were determined by qRT-PCR and/or western-blot. In addition, immunofluorescence was performed to evaluate a-SMA expression in HK-2 cells under different treatments. Bioinformatics analyses revealed miR-30b-5p had complementary sequences with SNAI1 mRNA and the seed region of miR-30b-5p was conserved in human and a variety of animals, including mice. Microarray analysis showed miR-30b expression decreased in DN mice, which was further verified in db/db mice by qRT-PCR and in human DN by FISH. Contrary to miR-30b-5p, SNAI1 expression level was upregulated in db/db mice. Correlation analysis suggested SNAI1 mRNA level was negatively with miR-30b-5p level in renal tissue of db/db mice. Luciferase reporter gene assay confirmed miR-30b-5p directly targeted SNAI1 mRNA. In high glucose induced HK-2 cells, expression levels of miR-30b-5p and E-cadherin were decreased, while SNAI1, a-SMA and Vimentin were increased. Overexpression miR-30b-5p in high glucose induced HK-2 cells could reverse that phenomenon to some extent. These findings suggest that miR-30b-5p play a protective role by targeting SNAI1 in renal EMT in DN.
Identifiants
pubmed: 33383483
pii: S0006-291X(20)32025-8
doi: 10.1016/j.bbrc.2020.10.096
pii:
doi:
Substances chimiques
Cadherins
0
MIRN30b microRNA, human
0
MicroRNAs
0
Mirn30d microRNA, mouse
0
SNAI1 protein, human
0
Snai1 protein, mouse
0
Snail Family Transcription Factors
0
Vimentin
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12-18Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.